• Western blot analysis of extracts of LNCaP cells, using PSA/KLK3 antibody (STJ11103562) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) (STJS000856) at 1:10000 dilution. Lysates/proteins: 25 Mu g per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 10s.

Anti-PSA/KLK3 antibody (162-261) [S2MR] (STJ11103562)

SKU:
STJ11103562

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit monoclonal antibody anti-PSA/KLK3 (162-261) is suitable for use in Western Blot research applications.
Clonality: Monoclonal
Clone ID: S2MR
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.02% Sodium Azide, 0.05% BSA, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:1000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: KLK3
Gene ID: 354
Uniprot ID: KLK3_HUMAN
Immunogen Region: 162-261
Immunogen: A synthetic peptide corresponding to a sequence within amino acids 162-261 of human PSA/KLK3 (P07288).
Immunogen Sequence: PEEFLTPKKLQCVDLHVISN DVCAQVHPQKVTKFMLCAGR WTGGKSTCSGDSGGPLVCNG VLQGITSWGSEPCALPERPS LYTKVVHYRKWIKDTIVANP
Function Hydrolyzes semenogelin-1 thus leading to the liquefaction of the seminal coagulum.
Protein Name Prostate-Specific Antigen
Psa
Gamma-Seminoprotein
Seminin
Kallikrein-3
P-30 Antigen
Semenogelase
Database Links Reactome: R-HSA-381426
Reactome: R-HSA-5625886
Cellular Localisation Secreted
Alternative Antibody Names Anti-Prostate-Specific Antigen antibody
Anti-Psa antibody
Anti-Gamma-Seminoprotein antibody
Anti-Seminin antibody
Anti-Kallikrein-3 antibody
Anti-P-30 Antigen antibody
Anti-Semenogelase antibody
Anti-KLK3 antibody
Anti-APS antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance